CYP1A1 Variability In Human Populations by Cristina Martínez-Labarga et al.
165
a https://databases.lovd.nl/shared/genes/CYP1A1 
Received for publication April 3, 2019
Introduction
Cytochrome P4501A1 (CYP1A1), one of three members 
of the CYP1 family, is mainly expressed in extra-hepatic 
tissues and is considered an essential enzyme in carcino-
gen metabolism The CYP1A1 gene is located at 15q22–
q24, spans 5,810 base pairs, and contains seven exons and 
six introns1. Numerous nucleotide changes in the CYP1A1 
human gene have been identified and described,a and 
some of them display inter-population frequency varia-
tions, even though only a limited number of populations 
were examined. More specifically, four point mutations, 
were analysed, and some were correlated with risk of tox-
icity or cancer and with the clinical efficacy of some che-
motherapies2–4. 
Mutations rs46469035 and m3 at g.750122356 are lo-
cated in the 3’–flanking region downstream of exon 7, do 
not cause amino acid changes, and generate an MspI re-
striction site. Two other mutations are located in exon 7 
and are non-synonymous: mutation rs1048943 (deter-
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A B S T R A C T
The human cytochrome P4501A1 (CYP1A1) enzyme plays an important role in the metabolism of xenobiotics and en-
dogenous substrates. Because polymorphisms within the CYP1A1 gene have been shown to be associated with various 
cancer risks and with the predicting clinical efficacy of some chemotherapies in different populations, most studies focus 
on their clinical significance. We, however, were interested in evaluating whether the polymorphisms could be used to dis-
tinguish human populations. Four single nucleotide CYP1A1 polymorphisms (rs4646903/ g.75011641; rs1048943/g.75012985; 
g.75012235; and rs1799814/ g.75012987) were analysed via PCR-RFLP assay in 1,195 individuals of various human groups 
from all over the world. In order to gain a more complete view of the genetic variability of the CYP1A1 gene, different sta-
tistical analyses were performed upon the populations of the present study and upon the limited data gleaned from previ-
ously studied populations. The allele and haplotype frequencies vary among populations: the rs4646903 (C) and rs1048943 
(G) have been found to be nearly always linked and were found at the highest frequencies in Native Americans, while the 
variant associated to the position g.75012235 was only detected in certain African populations. Our work clearly indicates 
that the CYP1A1 polymorphisms differ among populations and that the prediction of genotypes constitutes an important 
aspect of precision medicine since some variants were associated with certain cancers and rs1048943 show strong associa-
tion with optimized chemotherapy. Moreover, the CYP1A1 gene plays an important role in the metabolism of xenobiotics 
and it is likely that its frequencies could be strongly influenced by environmental factors. 
Keywords: P4501A1, nuclear polymorphisms, single-nucleotide polymorphisms (SNPs), restriction fragment length 
polymorphism (RFLP), human populations
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mined through the loss of a BsrDI restriction site) leads 
to an isoleucine to valine exchange in codon 4627, while 
the contiguous rs1799814 (not digested with the BsaI re-
striction enzyme) causes the substitution of threonine 461 
with asparagine8. The allele frequency at these four sites 
varies among different populations; rs4646903 (C) and 
rs1048943 (G) have been found to be nearly always linked, 
and m3 (C) has been detected only in African populations9. 
In this paper we report the allele and haplotype frequency 
distributions of the four CYP1A1 mutations in several hu-
man populations from across the globe.
Material and Methods 
One thousand one hundred and ninety five unrelated 
and apparently healthy subjects of both sexes belonging 
to various worldwide populations were analysed after they 
gave the appropriate informed consent. The subjects in-
cluded 60 people from the north African city of Al Fayyum, 
middle Egypt, 130 km southwest of Cairo; 177 from Benin, 
western Africa, belonging to four ethnic groups: 50 Fon, 
42 Bariba, 35 Berba, and 50 Dendi; 158 from eastern Af-
rica: 70 Oromo from Asella, city of the Oromia Region, 
central Ethiopia, and 88 Amhara from Ethiopia. They also 
included 413 Europeans so subdivided: 100 from central 
and southern Italy (51 from Molise, 25 from Lazio, 12 from 
Campania, 8 from Apulia, and 4 from Abruzzo); 100 Cro-
ats from different villages of the island of Korčula; 26 
individuals belonging to a Croatian community residing 
in the southern Italian region of Molise; 90 Spaniards 
from Alcalá de Henares, located 35 km northeast of Ma-
drid; 43 Spaniards sampled in La Vera and Bejar Valleys, 
Sierra de Gredos, in central Spain; and 54 Serbs sampled 
near the Studenica monastery, 39 km southwest of Kralje-
vo, in central Serbia. Additionally, there were 58 Arabs 
from the city of Dubai, United Arab Emirates (UAE); 68 
Asians from Siberia; 142 Ecuadorian Native Americans: 
65 Cayapa Indians (Chachi) sampled along the Cayapas 
river, and 77 Tsachilla (or Colorado Indians); 119 donors 
from two Ecuadorian communities of African ancestry liv-
ing in the Esmeraldas province: 73 along Rio Cayapas, and 
46 in Viche village. 
The study protocol was approved by the Ethical Com-
mittee of the University of Rome Tor Vergata for each 
population (Registro sperimentazione N.142/10, 88/11, 
89/11, 90/11, 92/11).
Genomic DNA was extracted from whole blood or oral 
swabs using standard procedures10. The four known CY-
P1A1 mutations were identified by PCR-RFLP analysis 
under the conditions reported in Table 1. The amplifica-
tions and enzymatic digestions were performed according 
to Cascorbi et al8 and Martínez-Labarga et al.11. In order 
TABLE 1
PCR AND RFLP ANALYSIS CONDITIONS
















































BsaI m4: 204 wt4: 139+65
* Primers reported in Martínez-Labarga et al.11
** Primers reported in Cascorbi et al.8
§  The detection of rs4646903 and m3 mutations for the best preserved samples was achieved through the only amplification of 899 bp frag-
ment using the primers M3F and P80, according to Cascorbi et al.8
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calculated and reported in Table 5. Seven new haplotypes, 
not reported in the official CYP1A1 websiteb, were ob-
served, at low frequencies. The frequencies obtained with 
the maximum-likelihood method are discussed and used 
in further analyses since the frequencies of some haplo-
types were only detected with the Bayesian method. The 
allele frequencies of the populations analysed in the pres-
ent research were compared with previously published 
data. 
Concerning the American continent, excluded from the 
graphic representation, rs4646903 frequencies are very 
high in the two Native American populations analysed, 
Cayapa and Tsachilla (80.8% and 68.2%, respectively), as 
in other Native Americans, in some of which this marker 
reaches fixation (100%;18,19. Likewise, rs1048943 was 
found to have the highest frequency in the Cayapa and 
Tsachilla (73.8% and 77.9%); also in this case these results 
can be compared to those of other Native Americans like 
the Achè, for instance, who reached fixation also for this 
marker18. These high frequencies support the hypothesis 
that attributes the loss of genetic variation to the founder 
effect that occurred during the peopling of the Americas 
from Asia20–24. As regards the variants g.75012235 and 
rs1799814, the Native American populations so far anal-
ysed show null or very low frequencies.
For Africa, Asia, and Europe, the single-marker data 
were graphically represented through the conversion of 
allele frequencies into contour maps (Figures 1a, 1b, 1c, 
1d) to visualize the geographical distribution of each 
marker. Although Surfer analysis has some limitations, it 
is a useful method to display the allele distributions. In 
the complex, it has highlighted a clinal distribution for the 
four markers. The colour gradient for marker rs4646903 
(Figure 1a) shows the deeper intensity of the orange colour 
in eastern Asia and in western Africa. The Middle East-
ern regions present intermediate intensities between 
those observed in the Asian and in the African popula-
tions, while lighter colours characterize Europe and north 
and eastern Africa. The only exception concerns the Span-
iards from Sierra de Gredos, in whom the loss of this allele 
could have been caused by their geographical isolation, as 
the sample examined comes from a small mountain com-
munity that has been isolated for centuries25–30. Moreover, 
to confirm the RFLP results, some samples were se-
quenced by fluorescent dye labelling on an ABI PRISM 
3130 AVANT DNA Sequencer (Life Technologies, Foster 
City, CA), following the manufacturer’s protocols. 
CYP1A1 alleles were named following the classifica-
tion proposed by Cascorbi et al.8 and the actually recom-
mended nomenclature for the genetic polymorphisms in 
human P450 genes reported in Table 2. 
Allele frequencies were computed by gene counting, 
and the Hardy-Weinberg equilibrium was then evaluated 
for each sample with polymorphic results. The allele fre-
quencies were graphically represented through the soft-
ware SURFER 6 (www.goldensoftware.com) to visualize 
their geographical cline distribution using the data re-
ported in Supplementary Table 1. The American continent 
was excluded from this analysis due to the high genetic 
homogeneity of the Native populations and the expected 
low variability of colour gradients.
Haplotype frequencies were computed twice in order to 
strengthen the reconstructed haplotypes: first using the 
software ARLEQUIN v3.512 and the maximum-likelihood 
method, and second using the software PHASE v2.013 and 
a Bayesian method. In order to gain a more complete view 
of the genetic variability of the CYP1A1 gene, Reynolds et 
al.’s14 genetic distances matrix calculated from genotypes 
of the populations analysed in the present study and those 
populations, collected from literature, previously tested 
for all four markers, with ARLEQUIN v3.5 were graphi-
cally represented through non-metric Multidimensional 
Scaling analysis (nm-MDS)15, using the STATISTICA 
software package16 . The partition of genetic variation be-
tween and within populations was carried out by assign-
ing the investigated populations to seven groups according 
to their geographical position; this was accomplished 
through an Analysis of Molecular Variance (AMOVA)17 by 
comparing haplotype frequencies. 
Results and Discussion
Allele frequencies for all populations are shown in 
Table 3. All the populations were in Hardy-Weinberg equi-
librium at all SNPs. The combined genotype frequencies 
at the four markers are reported in Table 4. For all the 
populations of this study, the haplotype frequencies were 
TABLE 2







Protein DNA change 
(genomic) (hg19)
Variant remark dbSNP ID
c.1382C>A m4 2452 C>A p.(Thr461Asn) g.75012987G>T haplotype CYP1A1*4 rs1799814
c.1384A>G m2 2454 A>G p.(Ile462Val) g.75012985T>C haplotype CYP1A1*2C rs1048943
c.1384A>G 2454 A>G
3798 T>C
p.(Ile462Val) g.75012985T>C haplotype CYP1A1*2B -
c.2134T>C m3 3204 T>C p.(=) g.75012235A>G haplotype CYP1A1*3 -
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the Africans from Benin and the Ecuadorian populations 
of African origin (Rio Cayapas and Viche) not surpris-
ingly differ statistically from the other African popula-
tions: the Amhara, Oromo, and Egyptians. The lower 
frequencies observed for the latter populations are the 
result of the heterogeneous genetic structure of Ethiopians 
and Egyptians, for whom a Eurasian genetic component 
was attested by previous studies on uniparental and au-
tosomal markers31–36.
The marker rs1048943 (Figure 1b) presents the deeper 
intensity of the pink colour in the Middle Eastern and 
Asian regions. In Africa its presence is observed only in 
north-eastern populations. In fact, the African popula-
tions of the present study were found monomorphic wild-
type for this marker with the exception for rs4646903, of 
the Egyptians (4.2%) and Amhara (6.8%). In the two Ec-
uadorian communities of African ancestry, the Rio Cay-
apas and Viche, the resulting frequencies were variable 
and statistically different, 4.8% and 19.6%, respectively, 
due to the higher Amerindian contribution to the Viche 
gene pool than to that of the Rio Cayapas37–39. In Europe 
its frequency slightly increases, reaching a more notice-
TABLE 3
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able colouring in Croatia. Three groups of European ori-
gin from Pôrto Alegre19, Rio de Janiero40, and Australia41 
resulted in slightly higher frequencies (11.6%, 8%, and 
7%, respectively) probably due to genetic contributions 
from Native populations.
The values of the g.75012235 (C) marker (Figure 1c) 
confirm its African origin: it is present only in the African 
and African-derived samples (0.7–7.5%) and in the UAE 
Arabs with a 1% frequency, due to admixture with differ-
ent African groups42. 
The deeper intensity of the violet colour related to the 
marker rs1799814 (Figure 1d) is localized in north-east-
ern Africa, with frequencies varying between 12.1% and 
22.5% in the Ethiopians and Egyptians, highlighting an 
evident expansion toward the Middle Eastern regions that 
supports the presence of a migration “corridor” between 
these two areas. Concerning the European continent, a 
darker colouring is noticed in the Iberian Peninsula, while 
Siberians have a low frequency (1.5%).
In the next step, the haplotype frequencies obtained in 
this study were compared with those available for other 
populations, supporting what emerged from the analysis 
of the single polymorphisms. Haplotype *2B (CGTC), de-
fined by the presence of both mutations rs4646903 (C) and 
rs1048943 (G), had the highest frequency in the Native 
Americans: 67.5% in the Tsachilla and 70.5% in the Cay-
apa. This confirms the results obtained considering the 
single mutations rs4646903 (C) and rs1048943 (G), which 
both reached the highest values precisely in Native Amer-
icans, and in some groups have reached fixation18–19. These 
high frequencies support the hypothesis that attributes 
the loss of genetic variation to the founder effect that oc-
curred during the peopling of the Americas from Asia. 
Haplotypes *2A (CATC) and *2C (CGTT), characterized 
respectively by either the mutation rs4646903 (C) or 
rs1048943 (G), were found to have quite variable values.
In the Asians and Africans, as well as the populations 
of African, Middle Eastern, or European ancestry, the 
haplotype *2B’s (CGTC) frequency decreases considerably 
(in some African and European groups this haplotype was 
found to be null). This is compensated by an increase of 
the haplotype *1 (CATT), which presents the wild-type 
form of all four markers, with values between 47.7% and 
93%. Even here the haplotypes *2A (CATC) and *2C 
(CGTT) showed a considerably variable fluctuation.
Haplotype *3 (CACT) is characterized by the mutation 
g.75012235 and therefore was detected exclusively in Af-
ricans and in groups of African ancestry ranging between 
0.7% and 7.4%. The only exception concerns the UAE 
Fig. 1. Geographical distribution of CYP1A1 variants: (a) rs4646903, g.75011641; (b) rs1048943, g.75012985; (c) g.75012235; and (d) 
rs1799814, g.75012987. The legend at the top and left side of the figure relates the allele frequencies with different color gradations: 
the deepest color intensity corresponds to the highest allele frequency
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sample (1%), due to admixture with different African 
groups42.
The presence of the mutation in rs1799814 character-
izes the haplotype *4 (AATT). This last haplotype was 
found to have the highest frequencies in north and eastern 
Africans (12.1%–18.9%), followed by Europeans (1%–
9.4%) and Middle Eastern groups (5.1% and 5.7%). Null 
frequencies were found in the groups with African ances-
try and in the populations from Benin, Japan, and the 
Cayapa.
The AMOVA was carried out by assigning the investi-
gated populations to seven groups according to their geo-
graphical position. The estimates of genetic variation 
among populations and within populations are 27.69 and 
71.62%, respectively, confirming that these four variants 
present a clear different geographical distribution8, 9, 11, 43.
pool of the Spanish population. The Serbs and the Croats 
from Korcula are very close to the Middle Eastern groups, 
because of admixture in the Balkan populations with 
these groups, as already reported. The position of the 
north-eastern Africans in relation to the south Saharans 
is evidence of their closer relationship with the Europeans. 
The two Afro-Ecuadorian groups, the Rio Cayapas and 
Viche, maintain different relationships with the other 
groups on the plot: the Viche lies closer to the Asians and 
therefore to the Native Americans while the Rio Cayapas 
are clearly adjacent to the south Saharans38. This denotes 
a pronounced African influence among the Rio Cayapas. 
We are therefore not surprised to observe that the Asians 
and the Viche are the closest group to the Native Ameri-
cans. Both the Middle Eastern samples stand between the 
Europeans, Asians, and South Saharans, confirming the 
contribution of all three groups to the Arab and Turkish 
genetic pool, especially of the Europeans for the Turkish.
Similar distribution was observed in the two-dimen-
sional plot of the correspondence analysis calculated from 
allele and haplotype frequencies (data not shown), which 
accounted for 74.22% of the total variability, which con-
firms what was deduced in the previous analysis from the 
genotypes.
In conclusion, this study has provided allele and hap-
lotype frequencies of the four markers of the CYP1A1 gene 
in populations that have never been analysed before, con-
firming the importance of these markers. Moreover, the 
knowledge of genetic variability in CYP450 gene could be 
the starting point and represents a step towards personal-
ized and optimized palliative chemotherapy44.
Because the functional role of the genes belonging to 
the cytochrome P450 subfamily are involved in the de-
toxification and bioactivation of common environmental 
pollutants in several species, it is likely that its frequen-
cies could be strongly influenced by environmental factors. 
However, Voight and colleagues45 analysed and mapped 
the recent positive selection in the human genome because 
it is known that the selective pressure to local environ-
mental conditions occurred during the most recent stages 
of Homo sapiens’ evolution. Selection was observed in some 
electron transport genes of the CYP450 gene cluster on 
chromosome 1 and in other genes belonging to the same 
gene family, such as CYP3A5, CYP2E1, and CYP1A2, but 
not in the CYP1A1 gene.
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Figure 2 reports the two-dimensional plot of the nm-
MDS analysis of the genetic distance matrix obtained by 
Reynolds et al.14 using the individual genotypes. The first 
dimension distributes the populations into two groups: the 
Native Americans on the right side and all the other pop-
ulations on the left, with the Asians and the African Ec-
uadorians from Viche occupying an intermediate position. 
Considering the second dimension, the Europeans lie cen-
trally, very close to the north-eastern Africans on the top 
side. Below are the south Saharan Africans and the 
groups of African origin more or less associated with 
Asians. Middle Eastern groups lie centrally between Af-
ricans, Asians, and Europeans. As for the Europeans, the 
Spaniards’ results were closer to those of the two north 
African groups, the Oromo and the Amhara. This could 
once again indicate an African contribution to the gene 
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VARIJABILNOST CYP1A1 U LJUDSKIM POPULACIJAMA
S A Ž E T A K
Ljudski enzim citokrom P4501A1 (CYP1A1) igra važnu ulogu u metabolizmu ksenobiotika i endogenih supstrata. 
Budući da se pokazalo kako su polimorfizmi gena CYP1A1 povezani s različitim rizikom od raka i predviđanjem kliničke 
učinkovitosti nekih kemoterapija u različitim populacijama, većina studija usredotočuje se na njihov klinički značaj. 
Ovaj rad, međutim, nastoji procijeniti mogu li se polimorfizmi upotrijebiti za razlikovanje ljudskih populacija. Četiri 
polimorfizma nukleotida CYP1A1 (rs4646903 / g.75011641; rs1048943 / g.75012985; g.75012235; i rs1799814 / g.75012987) 
analizirana su pomoću PCR-RFLP testa na 1.195 pripadnika različitih ljudskih grupa iz cijelog svijeta. Kako bi se dobio 
cjelovitiji prikaz varijabilnosti gena CYP1A1, provedene su različite statističke analize na uzorku iz ovog istraživanja 
studije i na ograničenom broju podataka dobivenih iz prethodno proučavanih populacija. Učestalost alela i haplotipa 
varira među populacijama: pokazalo se da su rs4646903 (C) i rs1048943 (G) gotovo uvijek povezani i da imaju najviše 
frekvencije u američkim indijanskim populacijama, dok je varijanta povezana s položajem g.75012235 otkrivena samo 
u nekim afričkim populacijama. Rad jasno pokazuje da se polimorfizmi CYP1A1 razlikuju među ljudskim populacijima. 
Predviđanje genotipova predstavlja važan aspekt precizne medicine budući da su neke varijante povezane s određenim 
karcinomom a rs1048943 pokazuje jaku povezanost s optimiziranom kemoterapijom. Pored toga, gen CYP1A1 igra važnu 
ulogu u metabolizmu ksenobiotika i vjerojatno na njegovu učestalost utječu okolišni faktori.
